01Distinguish the instrument result from the sample result

Suppose a hypothetical assay has a supported calibration interval of 1–100 ng/mL for the solution it measures. An original sample concentration of 300 ng/mL would lie outside that direct interval. Extending the calibration line beyond 100 is not the same as measuring within it.

A fivefold dilution could instead produce a measured concentration of 60 ng/mL. Multiplying 60 by 5 gives the original-sample estimate of 300 ng/mL, provided the dilution procedure and measurement are valid.

These invented numbers explain a laboratory report. They are not instructions for preparing a product or administering a peptide.

02Look for evidence about the dilution step

ICH M10 describes dilution integrity as an assessment of whether sample dilution preserves accuracy and precision. Its chromatographic framework evaluates diluted quality-control samples above the upper quantification limit and relates routine dilution factors and concentrations to those assessed during validation.FDA / ICH M10 — Bioanalytical Method Validation and Study Sample Analysis (opens in a new tab)

The guidance concerns bioanalytical assays supporting nonclinical and clinical studies. It is a useful explicit example of the principle; it does not automatically impose those procedures on every research-material certificate.

Evidence supporting a fivefold dilution at one concentration does not necessarily support a hundredfold dilution at a much higher concentration. Read the validated scope rather than interpreting the word validated as unlimited coverage.

03Ask what changed besides concentration

Dilution can change the surrounding matrix as well as the target concentration. If the changed matrix affects the analytical response or preparation behaviour, a simple factor may not fully describe the relationship to the original sample.

M10’s chromatographic dilution-integrity section addresses the dilution matrix and requires evidence that a surrogate matrix does not impair accuracy and precision where that alternative is used.FDA / ICH M10 — Bioanalytical Method Validation and Study Sample Analysis (opens in a new tab)

In a report review, identify the sample type, diluent or matrix, dilution factor and relevant validation reference. A factor recorded without the material context does not tell you whether the result follows the validated approach.

Also distinguish a deliberate dilution from a correction for a mistaken preparation. The former belongs to an established measurement model; the latter needs an investigation explaining the error and the validity of the revised calculation.

04Check the final number and its qualifiers

If the laboratory has already reported 300 ng/mL on the original-sample basis, multiplying by five again would incorrectly produce 1,500 ng/mL. Labels such as measured, calculated and dilution corrected should make the stage unambiguous.

An inequality also stays an inequality. If the diluted portion is reported as greater than 100 ng/mL after a valid fivefold dilution, the corresponding original-sample statement is greater than 500 ng/mL. It is not an exact measurement of 500.

If the diluted response falls below the supported quantification range, multiplication does not restore the missing quantitative capability. The final result needs the appropriate limitation and original-sample basis.

A clear report therefore connects the original sample identifier, measured portion, factor, supported range and final result. Missing links in that chain are clarification questions, even when the arithmetic itself is correct.